The mechanism of action of BCG therapy for bladder cancer—a current perspective | Nature Reviews Urology
Unraveling the Mechanism of the Antitumor Activity of Bacillus Calmette-Guérin - European Urology
Bacteria that activate natural killer cells to eliminate bladder cancer
Tumor-infiltrating immune cell subpopulations influence the oncologic outcome after intravesical Bacillus Calmette-Guérin therapy in bladder cancer | Oncotarget
Mechanisms of BCG in the treatment of bladder cancer-current understanding and the prospect - ScienceDirect
The battle field between BCG and Immune cells: The mechanism of... | Download Scientific Diagram
Cells | Free Full-Text | New Perspectives in the Medical Treatment of Non-Muscle-Invasive Bladder Cancer: Immune Checkpoint Inhibitors and Beyond | HTML
Frontiers | Nano-BCG: A Promising Delivery System for Treatment of Human Bladder Cancer | Pharmacology
Frontiers | BCG Against SARS-CoV-2: Second Youth of an Old Age Vaccine? | Pharmacology
References in BCG immunotherapy of bladder cancer: 20 years on - The Lancet
Mechanism responsible for the antitumor effect of BCG-CWS using the LEEL method in a mouse bladder cancer model - ScienceDirect
Use of bacille Calmette-Guérin in superficial bladder cancer | Postgraduate Medical Journal
Study Clarifies How Bladder Cancer Treatment Works | Memorial Sloan Kettering Cancer Center
Findings on Bacillus Calmette–Guérin (BCG) for Superficial Bladder Cancer | Leaders in Pharmaceutical Business Intelligence (LPBI) Group
Investigating the STING Pathway to Explain Mechanisms of BCG Failures in Non-Muscle Invasive Bladder Cancer: Prognostic and Therapeutic Implications - IOS Press
Proposed mechanism of action of MCNA. IN addition to an... | Download Scientific Diagram
Intravesical Bacillus Calmette-Guerin Therapy for Bladder Cancer: Molecular Mechanisms of Action | Bentham Science
Cytokines as effectors and predictors of responses in the treatment of bladder cancer by bacillus Calmette–Guérin | Future Oncology
Sequential Combination of Mitomycin C Plus Bacillus Calmette-Guérin (BCG) Is More Effective but More Toxic Than BCG Alone in Patients with Non–Muscle-invasive Bladder Cancer in Intermediate- and High-risk Patients: Final Outcome of
Bladder Ca biomarkers and BCG: New knowledge of the urinary microbiome
Mechanisms of immune evasion in bladder cancer | SpringerLink
The mechanism of action of BCG therapy for bladder cancer—a current perspective | Semantic Scholar
Trained immunity as a molecular mechanism for BCG immunotherapy in bladder cancer | Nature Reviews Urology
The Role of Interleukin-10 in Suppression of Bacillus Calmette-Guérin Induced T Helper Type 1Immune Response and Anti-Bladder Cancer Immunity
HLA-E and NKG2A as a novel immune checkpoint axis to improve treatment for non-muscle invasive bladder cancer | Horowitz Laboratory
